Skip to main content
Livermore
Livermore
ZHEN

Volitionrx Ltd

VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000093314

No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Volitionrx Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Volitionrx Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Volitionrx Ltd
NameTitleLast reported holdingLast filingFilings, past year
Forterre GaelChief Commercial Officer331,338Mar 19, 20268
Rootsaert Rodney GerardSecretary273,993Mar 19, 20268
Micallef Jacob VincentChief Scientific Officer572,179Mar 19, 20265
Plummer NicholasGC - Volition Diagnostics407,267Mar 19, 20267
Reynolds Cameron JohnPresident and CEO3,115,547Feb 27, 20264
Innes Guy ArchibaldDirector1,252,967Feb 27, 20263
Kway JasmineCEO - Singapore Volition418,614Feb 27, 20262
Hughes TerigChief Financial Officer684,970Feb 27, 20262
Nguyen KimDirector305,816Feb 27, 20262
Batchelor Ann-LouiseGroup Chief Marketing Officer324,072Feb 27, 20264
Rubin EthelDirector252,948Feb 27, 20262
Still Timothy IDirector1,625,458Jan 23, 20262
Colman AlanDirector257,364Jan 23, 20261
Barnes PhillipDirector67,368Jan 23, 20261
Butera Salvatore ThomasCEO - Volition Veterinary375,203Jan 23, 20264
Henshall MickieDirector44,206Jan 23, 20261
Retter AndrewChief Medical Officer146,568Nov 4, 20251
Gaetan MichelChief Operating Officer256,746Oct 7, 20252
Futcher EdwardDirector80,436Jan 26, 20240
Faulkes Martin CharlesExecutive Director1,740,207Jan 26, 20240
Hever Investments Ltd10% Owner298,419IndirectJan 3, 20240
Eight Corp Ltd10% Owner298,419IndirectJan 3, 20240
Brudnick RichardDirector27,936Jan 13, 20230
Terrell Jason Bradley MDChief Medical Officer2,326IndirectAug 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 4, 2025 (view filing)Jun 31 dayInnes Guy ArchibaldDirectorPPurchase+20.0K$0.54+$10.8K+2.3%888.7K after
Jun 16, 2025 (view filing)Jun 124 daysReynolds Cameron JohnPresident and CEOPPurchase+12.5K$0.59+$7.38K+0.5%2.33M after
Aug 6, 2025 (view filing)Aug 51 dayReynolds Cameron JohnPresident and CEOPPurchase+78.1K$0.64+$50.0K+3.1%2.61M after
Aug 6, 2025 (view filing)Aug 51 dayInnes Guy ArchibaldDirectorPPurchase+78.1K$0.64+$50.0K+8.8%966.8K after
Sep 15, 2025 (view filing)Sep 123 daysReynolds Cameron JohnPresident and CEOPPurchase+15.0K$0.66+$9.90K+0.6%2.62M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayStill Timothy IDirectorPPurchase+48.1K$0.51+$24.5K+3.2%1.54M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayStill Timothy IDirectorPPurchase+48.1K$0.01+$480.76–48.1K afterDerivative
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayInnes Guy ArchibaldDirectorPPurchase+96.2K$0.51+$49.0K+9.9%1.06M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayInnes Guy ArchibaldDirectorPPurchase+96.2K$0.01+$961.53–96.2K afterDerivative
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayReynolds Cameron JohnPresident and CEOPPurchase+110.0K$0.51+$56.1K+4.5%2.53M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayReynolds Cameron JohnPresident and CEOPPurchase+110.0K$0.01+$1.10K–110.0K afterDerivative
Nov 17, 2025 (view filing)1:12 PM ETNov 17Same dayReynolds Cameron JohnPresident and CEOPPurchase+20.0K$0.35+$7.00K+0.8%2.55M after